Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia ( MLL )–rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study

Blood (2010) 116 (15): 2644–2650.

https://doi.org/10.1182/blood-2010-03-273532

Published: 2010

Journal Articles

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Blood (2010) 115 (16): 3206–3214.

https://doi.org/10.1182/blood-2009-10-248146

Published: 2010

Includes: Supplemental data

Journal Articles

In Infant ALL with t(4;11)/ MLL-AF4 Multiple and Phenotypically Distinct CD19+ BM Subsets Initiate Leukemia in NOD/SCID Mice..

Michela Bardini, Lilian Wittmann, Lilia Corral, Luca Lo Nigro, Zhi Ma, Rakesh Singh, Giuseppe Basso, Giulio De Rossi, Mel Greaves, Andrea Biondi, Giovanni Cazzaniga, Sten Eirik Jacobsen

Blood (2009) 114 (22): 1432.

https://doi.org/10.1182/blood.V114.22.1432.1432

Published: 2009

Journal Articles

Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients.

Valentino Conter, MD, Maria Grazia Valsecchi, PhD, Maurizio Aricò, Carmelo Rizzari, Rosanna Parasole, Chiara Messina, Giulio De Rossi, Elena Barisone, Luca Lo Nigro, Nicola Santoro, Ottavio Ziino, Franco Locatelli, Andrea Pession, Anna Maria Testi, Concetta Micalizzi, Andrea Biondi, Giuseppe Basso, Daniela Silvestri, Giuseppe Masera, MD

Blood (2009) 114 (22): 319.

https://doi.org/10.1182/blood.V114.22.319.319

Published: 2009

Journal Articles

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Blood (2009) 114 (22): 1195.

https://doi.org/10.1182/blood.V114.22.1195.1195

Published: 2009

Journal Articles

Clofarabine in Combination with Etoposide and Cyclophosphamide (CLOVE) in Pediatric Patients with Relapsed Acute Leukemia: 4 Italian Pediatric AIEOP Centers’ Experience

Concetta Micalizzi, MD, Rosanna Parasole, Maria Caterina Putti, MD, Matteo Luciani, MD, Laura Banov, MD, Fara Petruzziello, Chiara Messina, Giulio De Rossi

Blood (2008) 112 (11): 3953.

https://doi.org/10.1182/blood.V112.11.3953.3953

Published: 2008

Journal Articles

Impact of Minimal Residual Disease (MRD) on Prognosis in Children with Philadelphia Positive Acute Lymphoblastic Leukemia (ALL) Treated in the AIEOP-BFM ALL 2000 Study.

Andrea Biondi, André Schrauder, Maria Grazia Valsecchi, Claus R Bartram, Georg Mann, Giulio De Rossi, Anja Möricke, Rosanna Parasole, Jochen Harbott, Chiara Messina, C. Rizzari, Giuseppe Masera, Martin Schrappe

Blood (2008) 112 (11): 1511.

https://doi.org/10.1182/blood.V112.11.1511.1511

Published: 2008

Journal Articles

Metylenetetrahydrofolate Reductase Polymorphism and Venous Thrombosis in Children

Matteo Luciani, MD, Valeria Pansini, MD, Valentina Coletti, MD, Daria Funaro, MD, Massimiliano Soldati, MD, Simona Pancotti, Piergiorgio Falappa, MD, Giulio De Rossi, MD

Blood (2008) 112 (11): 5357.

https://doi.org/10.1182/blood.V112.11.5357.5357

Published: 2008

Journal Articles

Prognostic Impact of Minimal Residual Disease (MRD) in Children Is Different in B or T Lineage Acute Lymphoblastic Leukemia: Results of Trial AIEOP-BFM ALL 2000.

Blood (2007) 110 (11): 1425.

https://doi.org/10.1182/blood.V110.11.1425.1425

Published: 2007

Journal Articles

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience

Maria Gabriella Mazzucconi, Paola Fazi, Sayla Bernasconi, Giulio De Rossi, Giuseppe Leone, Luigi Gugliotta, Nicola Vianelli, Giuseppe Avvisati, Francesco Rodeghiero, Angela Amendola, Carlo Baronci, Cecilia Carbone, Stefano Quattrin, Giuseppe Fioritoni, Giulio D'Alfonso, Franco Mandelli, for the Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Thrombocytopenia Working Party

Blood (2006) 109 (4): 1401–1407.

https://doi.org/10.1182/blood-2005-12-015222

Published: 2006

Journal Articles

High Dose Methotrexate (HD MTX at 2 gr/sqm x 4) Associated to Extended Intrathecal (IT) Chemotherapy Is Effective for Prevention of Central Nervous System (CNS) Relapse in Childhood ALL Treated with BFM Systemic Therapy.

Blood (2005) 106 (11): 10.

https://doi.org/10.1182/blood.V106.11.10.10

Published: 2005

Journal Articles

Children with TEL/AML1-Positive Acute Lymphoblastic Leukemia (ALL) and Favorable Presenting Features May Benefit from the Use of Vincristine-Dexamethasone (VCR-DXM) Pulses on Top of Antimetabolite-Based Continuation Therapy.

Blood (2005) 106 (11): 9.

https://doi.org/10.1182/blood.V106.11.9.9

Published: 2005

Journal Articles

Treatment Intensification of Traditional BFM Therapy with 3 Chemotherapy Blocks and Double Delayed Intensification (Protocol II) Improves Outcome in Infants with High Risk (HR) Acute Lymphoblastic Leukemia (ALL): Results of Two Consecutive AIEOP Studies.

Carmelo Rizzari, Maria Grazia Valsecchi, Paola De Lorenzo, Maurizio Aricò, Giuseppe Basso, Franco Locatelli, Luca Lo Nigro, Giulio De Rossi, Giuseppe Masera, Andrea Biondi

Blood (2005) 106 (11): 871.

https://doi.org/10.1182/blood.V106.11.871.871

Published: 2005

Journal Articles

GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children

Anna Maria Testi, Andrea Biondi, Francesco Lo Coco, Maria Luisa Moleti, Fiorina Giona, Marco Vignetti, Giuseppe Menna, Franco Locatelli, Andrea Pession, Elena Barisone, Giulio De Rossi, Daniela Diverio, Concetta Micalizzi, Maurizio Aricò, Giuseppe Basso, Robert Foa, Franco Mandelli

Blood (2005) 106 (2): 447–453.

https://doi.org/10.1182/blood-2004-05-1971

Published: 2005

Journal Articles

PTPN11 and RAS Gene Mutation Pattern Identifies an Unique Feature of Upregulated RAS Function in Infant ALL.

Giovanni Cazzaniga, PhD, Simone Martinelli, PhD, Monique L. den Boer, PhD, Lilia Corral, BSc, Monica Spinelli, PhD, Giuseppe Basso, MD, Giulio De Rossi, MD, Rob Pieters, MD, PhD, Marco Tartaglia, MD, PhD, Andrea Biondi, MD

Blood (2004) 104 (11): 996.

https://doi.org/10.1182/blood.V104.11.996.996

Published: 2004

Journal Articles

Three-Drug Induction and BFM-Type Intensive Consolidation Chemotherapy for Treatment of Standard Risk Childhood Acute Lymphoblastic Leukemia Defined Also by DNA index. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Study ALL-9501.

Maurizio Arico’, Valentino Conter, Maria Grazia Valsecchi, Marie France Pinta Boccalatte, Elena Barisone, Chiara Messina, Giulio De Rossi, Luca Lo Nigro, Andrea Pession, Franco Locatelli, Concetta Micalizzi, Giuseppe Basso, Giuseppe Masera

Blood (2004) 104 (11): 1951.

https://doi.org/10.1182/blood.V104.11.1951.1951

Published: 2004

Journal Articles

High Clonal Evolution Rate in Relapsing Infant ALL Patients.

Giovanni Cazzaniga, PhD, Lilia Corral, BSc, Matteo Luciani, MD, Simona Songia, Bsc, Paola De Lorenzo, PhD, Monica Spinelli, PhD, Luca Lo Nigro, MD, Giuseppe Basso, MD, Giulio De Rossi, MD, Andrea Biondi, MD

Blood (2004) 104 (11): 164.

https://doi.org/10.1182/blood.V104.11.164.164

Published: 2004

Journal Articles

Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II

Maurizio Aricò, Maria Grazia Valsecchi, Valentino Conter, Carmelo Rizzari, Andrea Pession, Chiara Messina, Elena Barisone, Vincenzo Poggi, Giulio De Rossi, Franco Locatelli, Maria Concetta Micalizzi, Giuseppe Basso, Giuseppe Masera

Blood (2002) 100 (2): 420–426.

https://doi.org/10.1182/blood.V100.2.420

Published: 2002

Journal Articles

A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia

Giuseppe Cimino, Loredana Elia, Maria Cristina Rapanotti, Teresa Sprovieri, Marco Mancini, Antonio Cuneo, Cristina Mecucci, Giuseppe Fioritoni, Mario Carotenuto, Enrica Morra, Vincenzo Liso, Luciana Annino, Giuseppe Saglio, Giulio De Rossi, Robin Foà, Franco Mandelli

Blood (2000) 95 (1): 96–101.

https://doi.org/10.1182/blood.V95.1.96

Published: 2000

NARROW

Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia ( MLL )–rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

In Infant ALL with t(4;11)/ MLL-AF4 Multiple and Phenotypically Distinct CD19+ BM Subsets Initiate Leukemia in NOD/SCID Mice..

Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients.

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Clofarabine in Combination with Etoposide and Cyclophosphamide (CLOVE) in Pediatric Patients with Relapsed Acute Leukemia: 4 Italian Pediatric AIEOP Centers’ Experience

Impact of Minimal Residual Disease (MRD) on Prognosis in Children with Philadelphia Positive Acute Lymphoblastic Leukemia (ALL) Treated in the AIEOP-BFM ALL 2000 Study.

Metylenetetrahydrofolate Reductase Polymorphism and Venous Thrombosis in Children

Prognostic Impact of Minimal Residual Disease (MRD) in Children Is Different in B or T Lineage Acute Lymphoblastic Leukemia: Results of Trial AIEOP-BFM ALL 2000.

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience

High Dose Methotrexate (HD MTX at 2 gr/sqm x 4) Associated to Extended Intrathecal (IT) Chemotherapy Is Effective for Prevention of Central Nervous System (CNS) Relapse in Childhood ALL Treated with BFM Systemic Therapy.

Children with TEL/AML1-Positive Acute Lymphoblastic Leukemia (ALL) and Favorable Presenting Features May Benefit from the Use of Vincristine-Dexamethasone (VCR-DXM) Pulses on Top of Antimetabolite-Based Continuation Therapy.

Treatment Intensification of Traditional BFM Therapy with 3 Chemotherapy Blocks and Double Delayed Intensification (Protocol II) Improves Outcome in Infants with High Risk (HR) Acute Lymphoblastic Leukemia (ALL): Results of Two Consecutive AIEOP Studies.

GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children

PTPN11 and RAS Gene Mutation Pattern Identifies an Unique Feature of Upregulated RAS Function in Infant ALL.

Three-Drug Induction and BFM-Type Intensive Consolidation Chemotherapy for Treatment of Standard Risk Childhood Acute Lymphoblastic Leukemia Defined Also by DNA index. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Study ALL-9501.

High Clonal Evolution Rate in Relapsing Infant ALL Patients.

Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II

A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only